查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840667

全球泌尿系統市場（按產品類型、應用、最終用戶、分銷管道和技術）預測 2025-2032

Urology Market by Product Type, Application, End User, Distribution Channel, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年泌尿系統市場將成長至 1,298.5 億美元，複合年成長率為 10.59%。

主要市場統計數據
基準年2024年 580億美元
預計2025年 642.8億美元
預測年份：2032年 1298.5億美元
複合年成長率（%） 10.59%

為不斷變化的泌尿系統設備格局、不斷變化的臨床實踐和加速的技術創新提供明確的策略方向

泌尿系統醫療設備市場格局正因臨床需求的融合、人口結構趨勢和快速的技術創新而重塑。人口老化導致慢性和急性泌尿系統系統疾病的發生率上升，而醫療保健服務模式也正從住院轉向門診。同時，影像技術和微創工具的進步正在改變臨床路徑和臨床醫生的期望，迫使醫療保健提供者重新評估其資本配置和籌資策略。

因此，製造商、經銷商和醫療系統正在應對一個更複雜的環境，監管審查、感染預防重點和永續性考量交織在一起。付款人和供應商透過以結果為導向的採購和長期服務關係尋求價值，而數位管道正開始改變傳統的分銷動態。這些因素的共同作用要求對產品系列、通路投資和夥伴關係進行策略性清晰的規劃，以便在快速變化的環境中保持臨床相關性和商業性績效。

為什麼微創技術、診斷成像的進步、一次性使用和數位化分銷正在從根本上改變泌尿系統的臨床和商業模式

近年來，泌尿系統產業經歷了一場變革，重新定義了產品生命週期、採購方式和病患就診路徑。在先進影像處理和雷射技術的推動下，微創技術正在降低手術干預的閾值，縮短住院時間，並支持手術持續轉移到門診手術中心和門診。同時，感染控制重點、操作簡單性和總醫療成本計算的變化正在加速一次性器材的普及。

同時，數位整合和先進的影像技術正在協助實現更早的診斷和更精準的干涉，而人工智慧和先進的視覺化工具也開始影響設備設計和臨床工作流程。隨著電子商務和醫療直銷模式與傳統醫院採購模式的整合，分銷管道也不斷調整，從而帶來新的競爭壓力和定價動態。隨著這些轉變的持續，那些將設備創新、服務交付和跨職能專業知識與數據主導的臨床證據相結合的公司將更有能力抓住機遇，並緩解行業快速轉型帶來的營運和監管阻力。

評估 2025 年美國關稅對泌尿系統醫療設備採購、生產、採購和定價動態的廣泛營運和策略影響

美國2025年實施的關稅變化的累積效應，已在整個泌尿系統器械供應鏈中產生了一系列新的約束和獎勵。依賴進口零件的製造商面臨著不斷上升的投入成本，這迫使許多製造商重新評估籌資策略，並加快本地化生產或尋找合適的替代供應商。這些調整影響了定價策略、庫存政策和供應商契約，促使相關人員重新評估長期供應商關係和合約彈性。

醫療保健提供者和經銷商已採取應對措施，加強談判，優先考慮基於價值的採購，並研究其對包括服務和成本在內的總成本的影響。此外，一些醫療設備製造商正在將高價值的組裝和最終測試轉移到國內工廠，以減少關稅波動帶來的影響，並保持更可預測的前置作業時間。日益成長的監管合規和海關複雜性加重了行政負擔，從而有利於擁有強大供應鏈能力的大型公司。總體而言，關稅環境正在加速採購、生產佈局和貿易條款的結構性調整，促使製造商和負責人做出短期營運應對措施和長期策略重新定位。

詳細的細分框架，突顯推動臨床效用、採購行為和商業策略的產品、應用、最終用戶、通路和技術的差異

詳細查看細分市場可發現產品、應用、最終用戶、分銷和技術維度上的差異化需求、臨床效用和採購行為。按產品類型，市場細分為拋棄式和可重複使用設備，其中拋棄式設備包括導管和支架。導管進一步細分為Foley導管和間歇導管，支架進一步細分為腎造口支架和輸尿管支架。可重複使用器械包括內視鏡和手術器械，其中內視鏡進一步細分為軟式內視鏡內視鏡和硬式內視鏡。這些產品細分與感染控制優先順序、手術量和資本投資週期密切相關。

治療應用針對不同的臨床促進因素，例如前列腺增生治療、癌症診斷、結石去除和尿失禁管理，每種應用都有其獨特的臨床工作流程、報銷考慮和設備性能要求。最終用戶包括門診手術中心、診所和醫院，每家都有自己的採購管治、預算界限和營運限制。分銷管道涵蓋電子商務、醫​​院採購和零售藥局，數位管道日益影響著消耗品和小型設備的購買行為。影像技術本身涵蓋電腦斷層掃描、MRI 和超音波模式，為診斷途徑和程序規劃提供資訊。了解這些交叉細分市場有助於開發有針對性的產品、制定差異化的銷售策略以及根據臨床需求和購買者偏好客製化的服務模式。

美洲、歐洲、中東和非洲以及亞太地區的區域動態決定了泌尿系統設備的採購、監管參與和供應鏈彈性

美洲、歐洲、中東和非洲以及亞太地區的區域動態正在塑造競爭重點和投資選擇，每個地區都呈現不同的監管、報銷和供應鏈格局。在美洲，私人醫療機構、綜合醫院系統和門診手術中心的擴張推動了對縮短手術時間並支持當天出院的設備的需求，同時，分銷模式也擴大採用直接採購和耗材電商模式。

在歐洲、中東和非洲，採購通常受公共支付方和集中採購機制的影響，成本控制壓力與高標準的臨床證據和再處理並存，因此可重複使用器械在某些市場仍具有重要意義。在亞太地區，快速的醫療保健投資、不斷成長的手術量以及對本地製造能力的重視，正在加速微創技術、影像處理升級和混合分銷策略的採用。這些地區差異表明，需要製定區域化的商業策略，積極與監管機構溝通，並根據各地區的監管複雜性、採購成熟度和基礎設施發展情況，客製化供應鏈的彈性。

透過整合優先考慮策略夥伴關係、服務主導的產品供應、整合解決方案、售後服務和擴充性的參與者來增強產業的競爭動態

泌尿系統設備生態系內的競爭態勢日益呈現策略多元化、夥伴關係和服務導向經營模式的特徵。領先的製造商正在投資捆綁解決方案，將設備與培訓、資訊服務和維護合約相結合，以深化客戶關係並建立經常性收益來源。設備製造商、影像供應商和臨床中心之間的策略合作正在加速檢驗週期，並支援整合程式解決方案的廣泛應用。

同時，規模較小的創新企業正專注於利基市場、一次性替代品以及技術驅動的差異化，以期獲得臨床關注並吸引分銷合作夥伴。尋求在生產、監管專業知識和售後服務能力方面實現規模化的公司正在進行整合，而合約條款和服務水準承諾正成為採購決策的核心考慮因素。在這種環境下，那些將研發重點與明確的臨床價值提案和強大的售後支持相結合的公司將更有能力獲得持久的契約，並應對不斷變化的報銷和採購壓力。

產業領導者可以採取切實可行的高影響力行動來加強其供應鏈、推動臨床差異化、擴展以服務為導向的商業模式並確保永續成長

為了應對不斷變化的市場環境並實現永續成長，產業領導者應追求供應鏈韌性、臨床差異化和商業性敏捷性的結合。首先，實現供應商基礎多元化和關鍵製造流程在地化，將降低關稅波動風險並確保前置作業時間。其次，優先考慮那些能夠帶來可衡量臨床和經濟效益的產品特性，例如縮短手術時間、降低感染風險和降低總發病成本，這將增強其在注重價值的買家中的採購定位。

第三，圍繞設備銷售建立服務和培訓方案可以提高客戶維繫，並創造可預測的收益來源。第四，拓展耗材和低成本醫療設備的數位化和直銷診所銷售管道，可以補充傳統的醫院採購，並加快市場進入。最後，積極與監管機構和付款方溝通臨床證據和實際結果，可以支持有利的採用和報銷決策。總而言之，這些行動基於營運可靠性、臨床相關性和商業性靈活性，建構了可防禦的策略態勢。

強大的多方法調查方法結合臨床文獻、監管研究、專家訪談和檢驗，提供可操作和檢驗的業界考察

此研究方法融合了多學科投入，以確保分析的嚴謹性、三角測量和實踐相關性。二次研究包括系統性地回顧同儕審查的臨床文獻、監管備案文件、操作指南和公共文件，以繪製臨床路徑、技術採用和合規性要求。一次研究包括對臨床醫生、採購主管、供應鏈經理和產品開發人員進行結構化訪談，以了解現實世界的營運限制、偏好促進因素和採用障礙。來自製造商技術文件和產品註冊的數據提供了設備規格和功能比較。

我們根據採購方的採購框架和臨床專家的意見，對定性洞察檢驗，以確保其與實踐模式和採購理念相符。我們優先考慮調查方法和資料來源的透明度、資料來源的清晰記錄，以及由內部跨職能審查和外部專家檢驗組成的多層次檢驗流程。限制包括機構採購慣例的多樣性以及不斷變化的費率和監管指南；我們透過敏感度分析和情境規劃來應對這些問題，以發現合理的策略應對措施，而非單一的確定性結果。

最後，我們概述了將泌尿系統技術進步和供應鏈挑戰轉化為競爭優勢所需的策略重點和緊急行動。

摘要：泌尿系統醫療設備領域正處於曲折點，臨床創新、不斷變化的採購和供應鏈壓力交織在一起。向微創手術的轉變、一次性感染控制產品的興起以及先進影像處理和雷射技術的整合，正在重塑臨床路徑和買家期望。同時，關稅主導的成本動態以及採購和管理體制的區域差異，迫使企業在採購、定價和商業性參與方面保持敏捷。

未來的成功取決於整合的方法，該方法應將產品開發與明確的臨床價值相結合，增強服務和培訓能力，並建立供應鏈韌性。門診病人轉變、投資數位化和分銷靈活性，並在臨床、監管和商業職能部門之間開展協作的醫療保健提供者和製造商，將佔據有利地位，在保持財務和營運穩定的同時，實現患者療效的改善。現在做出的策略選擇將決定誰將在不斷變化的格局中獲勝。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 技術進步和患者需求導致前列腺和腎臟手術中機器人輔助腹腔鏡手術的增加。
  • 透過開發和實施用於前列腺癌早期檢測的非侵入性生物標記來改善患者預後
  • 前列腺增生的微創治療（如前列腺動脈栓塞和水蒸氣療法）的成長
  • 整合遠端醫療和遠端患者監護平台，用於區域泌尿系統實踐中的術後護理
  • 基於精準醫療方法的進行性尿路上皮癌合併標靶治療和免疫治療的激增
  • 引進人工智慧診斷影像分析，提高泌尿系統疾病檢測的準確性與效率

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章泌尿系統市場（依產品類型）

  • 免洗設備
    • 導管
      • Foley導管
      • 間歇導尿管
    • 支架
      • 腎臟造口支架
      • 輸尿管支架
  • 可重複使用的設備
    • 內視鏡檢查
      • 軟性內視鏡
      • 硬式內視鏡
    • 手術器械

第9章泌尿系統市場的應用

  • 良性攝護腺增生的治療
  • 癌症診斷
  • 去除結石
  • 尿失禁管理

第 10 章泌尿系統市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 醫院

第 11 章泌尿系統市場通路

  • 電子商務
  • 醫院採購
  • 零售藥局

第12章泌尿系統市場（按技術）

  • 成像技術
    • 電腦斷層掃描
    • MRI
    • 超音波
  • 雷射技術

第13章泌尿系統市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章泌尿系統市場：依類別

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章泌尿系統市場（按國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Boston Scientific Corporation
    • Johnson & Johnson
    • Olympus Corporation
    • Medtronic plc
    • Stryker Corporation
    • Coloplast A/S
    • Teleflex Incorporated
    • Becton, Dickinson and Company
    • STERIS plc
    • Baxter International Inc.
Product Code: MRR-0360AB17DF5A

The Urology Market is projected to grow by USD 129.85 billion at a CAGR of 10.59% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 58.00 billion
Estimated Year [2025] USD 64.28 billion
Forecast Year [2032] USD 129.85 billion
CAGR (%) 10.59%

A clear and strategic orientation to the evolving urology device landscape driven by demographic shifts, clinical practice change, and accelerating technological innovation

The urology device landscape is being reshaped by converging clinical needs, demographic trends, and rapid technological innovation. Aging populations are increasing the prevalence of chronic and acute urological conditions, while care-delivery models are shifting procedures from inpatient to ambulatory settings. In parallel, advances in imaging and minimally invasive tools are changing clinical pathways and clinician expectations, prompting providers to reassess capital allocation and procurement strategies.

Consequently, manufacturers, distributors, and health systems are navigating a more complex environment where regulatory scrutiny, infection-prevention priorities, and sustainability considerations intersect. Payers and providers seek value through outcome-driven procurement and long-term service relationships, and digital channels are beginning to alter traditional distribution dynamics. Taken together, these forces demand strategic clarity about product portfolios, channel investments, and partnerships that can sustain clinical relevance and commercial performance amid accelerating change.

How minimally invasive techniques, imaging advances, single-use adoption and digital distribution are fundamentally reshaping clinical practice and commercial models in urology

Over recent years the industry has experienced transformative shifts that are redefining product lifecycles, procurement practices, and patient pathways. Minimally invasive techniques, fueled by refined imaging and laser technology, are lowering thresholds for procedural intervention and shortening length of stay, which in turn supports the continued migration of procedures to ambulatory surgical centers and outpatient clinics. Simultaneously, the adoption of single-use disposable devices has accelerated, driven by infection-control priorities, operational simplicity, and changes in total cost-of-care calculations.

At the same time, digital integration and advanced imaging modalities are enabling earlier diagnosis and more precise interventions, while artificial intelligence and enhanced visualization tools are beginning to influence device design and clinical workflows. Distribution channels are adapting as e-commerce and direct-to-provider models gain traction alongside traditional hospital procurement, creating new competitive pressures and pricing dynamics. As these shifts continue, companies that integrate cross-functional expertise-combining device innovation, service delivery, and data-driven clinical evidence-will be better positioned to capture opportunities and mitigate the operational and regulatory headwinds that accompany rapid sector transformation.

Assessing the wide-ranging operational and strategic consequences of United States tariff actions in 2025 on sourcing, production, procurement and pricing dynamics across urology devices

The cumulative effects of tariff changes implemented in 2025 in the United States have created a new set of constraints and incentives across the urology device supply chain. Manufacturers reliant on imported components have faced increased input costs, prompting many to reassess sourcing strategies and accelerate initiatives to regionalize production or qualify alternative suppliers. These adjustments have affected pricing strategies, inventory policies, and supplier contracts, leading stakeholders to re-evaluate long-term supplier relationships and contractual flexibility.

Healthcare providers and distributors have responded by intensifying negotiations, prioritizing value-based purchasing, and increasing scrutiny of total cost implications, including service and consumable components. In addition, some device makers have shifted higher-value assembly and final testing to domestic facilities to reduce exposure to tariff volatility and to maintain more predictable lead times. Regulatory compliance and customs complexity have added administrative burdens, which in turn favor larger organizations with robust supply-chain functions. Overall, the tariff environment has accelerated structural adjustments in sourcing, production footprints, and commercial terms, prompting both near-term operational responses and longer-term strategic repositioning among manufacturers and purchasers.

Deep segmentation framework highlighting product, application, end-user, channel and technology distinctions that drive clinical utility, procurement behavior and commercial strategy

A granular view of segmentation reveals differentiated demand, clinical utility, and procurement behavior across product, application, end-user, distribution, and technology dimensions. By product type, the landscape separates into disposable devices and reusable devices, where disposable devices encompass catheters and stents; catheters further segment into Foley catheters and intermittent catheters while stents further divide into nephrostomy stents and ureteral stents. Reusable devices include endoscopes and surgical instruments, and endoscopes can be further categorized into flexible endoscopes and rigid endoscopes. These product distinctions correlate strongly with infection-control priorities, procedure volumes, and capital-investment cycles.

Applications map to distinct clinical drivers including benign prostatic hyperplasia treatment, cancer diagnosis, stone removal, and urinary incontinence management, each of which has specific clinical workflows, reimbursement considerations, and device-performance requirements. End users vary among ambulatory surgical centers, clinics, and hospitals, and each setting has unique procurement governance, budget horizons, and operational constraints. Distribution channels range across e-commerce, hospital purchases, and retail pharmacies, with digital channels progressively influencing purchasing behaviors for consumables and smaller devices. Technology segmentation encompasses imaging technology and laser technology; imaging technology itself spans CT scan, MRI, and ultrasound modalities, which inform diagnostic pathways and procedural planning. Understanding these intersecting segments enables targeted product development, differentiated sales strategies, and service models tailored to clinical needs and buyer preferences.

Regional dynamics across Americas, Europe, Middle East & Africa and Asia-Pacific shaping procurement, regulatory engagement, and supply-chain resilience for urology devices

Regional dynamics are shaping competitive priorities and investment choices across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct regulatory, reimbursement, and supply-chain contexts. In the Americas, a mix of private providers, consolidated hospital systems, and an expanding ambulatory surgical center footprint have heightened demand for devices that reduce procedure time and support same-day discharge, while distribution models reflect growing adoption of direct procurement and e-commerce for consumables.

Across Europe, the Middle East & Africa, procurement is often influenced by public payers and centralized purchasing mechanisms; cost-containment pressures coexist with a high bar for clinical evidence and reprocessing standards, which sustains the relevance of reusable equipment in some markets. In the Asia-Pacific region, rapid healthcare investment, expanding procedural volumes, and a focus on local manufacturing capacity are accelerating adoption of minimally invasive technologies, imaging upgrades, and hybrid distribution strategies. These regional distinctions imply that commercial tactics should be localized, regulatory engagement must be proactive, and supply-chain resilience tailored to each region's mix of regulatory complexity, procurement maturity, and infrastructure development.

Industry competitive dynamics driven by strategic partnerships, service-led offerings, and consolidation as players prioritize integrated solutions, aftersales and scalability

Competitive dynamics within the urology device ecosystem are increasingly characterized by strategic diversification, partnerships, and service-oriented business models. Leading manufacturers are investing in bundled solutions that combine devices with training, data services, and maintenance agreements to deepen customer relationships and create recurring revenue streams. Strategic collaborations between device makers, imaging providers, and clinical centers are accelerating validation cycles and supporting broader adoption of integrated procedural solutions.

At the same time, smaller innovators are focusing on niche indications, disposable alternatives, and technology-enabled differentiation to gain clinical traction and attract distribution partners. Consolidation activity continues as companies seek scale in manufacturing, regulatory expertise, and aftermarket service capabilities, while contract terms and service-level commitments have become central considerations in procurement decisions. In this environment, companies that align R&D priorities with clear clinical value propositions and robust post-sale support will be better positioned to secure durable contracts and navigate evolving reimbursement and procurement pressures.

Practical, high-impact actions for industry leaders to strengthen supply chains, differentiate clinically, and expand service-oriented commercial models to secure durable growth

To navigate the evolving landscape and capture sustainable growth, industry leaders should pursue a combination of supply-chain resilience, clinical differentiation, and commercial agility. First, diversifying supplier bases and regionalizing critical manufacturing steps reduces exposure to tariff volatility and protects lead times, while investments in inventory visibility and flexible contract terms improve operational resilience. Second, prioritizing product features that demonstrate measurable clinical and economic benefits-such as reduced procedure time, lower infection risk, or decreased total episode cost-will enhance procurement positioning with value-minded buyers.

Third, building service and training packages that accompany device sales increases customer retention and creates predictable revenue streams, particularly for providers shifting procedures to outpatient settings. Fourth, expanding digital and direct-to-provider distribution channels for consumables and lower-cost devices complements traditional hospital purchasing and enables faster market access. Finally, engaging proactively with regulators and payers to communicate clinical evidence and real-world outcomes will support favorable adoption and reimbursement decisions. Executed together, these actions create a defensible strategic posture grounded in operational reliability, clinical relevance, and commercial flexibility.

Robust, multi-method research methodology combining clinical literature, regulatory review, expert interviews and validation to produce actionable and verifiable industry insights

The research approach combined multi-disciplinary inputs to ensure analytical rigor, triangulation, and practical relevance. Secondary research involved systematic review of peer-reviewed clinical literature, regulatory filings, procedural guidelines, and public policy documents to map clinical pathways, technology adoption, and compliance requirements. Primary research included structured interviews with clinicians, procurement leaders, supply-chain managers, and product developers to capture real-world operational constraints, preference drivers, and adoption barriers. Data from manufacturer technical documentation and product registries informed device specifications and functional comparisons.

Qualitative insights were validated against purchaser procurement frameworks and clinical experts to ensure alignment with practice patterns and purchasing rationales. The methodology prioritized transparency in assumptions, explicit documentation of data sources, and a layered validation process comprising internal cross-functional review and external expert validation. Limitations include variability in institutional procurement practices and the evolving nature of tariffs and regulatory guidance, which were addressed through sensitivity analyses and scenario planning to illuminate plausible strategic responses rather than singular deterministic outcomes.

Concluding synthesis of strategic priorities and urgent actions required to translate technological advances and supply-chain challenges into competitive advantage in urology

In summary, the urology device environment is at an inflection point where clinical innovation, procurement evolution, and supply-chain pressures intersect. The shift toward minimally invasive techniques, the rise of disposable options for infection control, and the integration of advanced imaging and laser technologies are reshaping clinical pathways and buyer expectations. Concurrently, tariff-driven cost dynamics and regional variations in procurement and regulatory regimes require companies to be nimble in sourcing, pricing, and commercial engagement.

Looking forward, success will depend on an integrated approach that aligns product development with clear clinical value, reinforces service and training capabilities, and builds supply-chain resilience. Providers and manufacturers who proactively adapt to outpatient migration, invest in digital and distribution flexibility, and collaborate across clinical, regulatory, and commercial functions will be better positioned to deliver improved patient outcomes while maintaining financial and operational stability. The time to act is immediate, as strategic choices made now will determine who captures advantage as the landscape continues to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rise of robotic-assisted laparoscopic surgeries for prostate and kidney procedures driven by technological advances and patient demand
  • 5.2. Development and adoption of non-invasive biomarkers for early detection of prostate cancer to improve patient outcomes
  • 5.3. Growth in minimally invasive therapies for benign prostatic hyperplasia like prostate artery embolization and water vapor therapy
  • 5.4. Integration of telemedicine and remote patient monitoring platforms for post-surgical care in urology practices across regions
  • 5.5. Surge in targeted therapies and immunotherapy combinations for advanced urothelial carcinoma based on precision medicine approaches
  • 5.6. Adoption of AI-powered diagnostic imaging analysis to enhance accuracy and efficiency in urologic disease detection

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urology Market, by Product Type

  • 8.1. Disposable Devices
    • 8.1.1. Catheters
      • 8.1.1.1. Foley Catheters
      • 8.1.1.2. Intermittent Catheters
    • 8.1.2. Stents
      • 8.1.2.1. Nephrostomy Stents
      • 8.1.2.2. Ureteral Stents
  • 8.2. Reusable Devices
    • 8.2.1. Endoscopes
      • 8.2.1.1. Flexible Endoscopes
      • 8.2.1.2. Rigid Endoscopes
    • 8.2.2. Surgical Instruments

9. Urology Market, by Application

  • 9.1. Benign Prostatic Hyperplasia Treatment
  • 9.2. Cancer Diagnosis
  • 9.3. Stone Removal
  • 9.4. Urinary Incontinence Management

10. Urology Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Urology Market, by Distribution Channel

  • 11.1. E-Commerce
  • 11.2. Hospital Purchases
  • 11.3. Retail Pharmacies

12. Urology Market, by Technology

  • 12.1. Imaging Technology
    • 12.1.1. CT Scan
    • 12.1.2. MRI
    • 12.1.3. Ultrasound
  • 12.2. Laser Technology

13. Urology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Urology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Urology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Boston Scientific Corporation
    • 16.3.2. Johnson & Johnson
    • 16.3.3. Olympus Corporation
    • 16.3.4. Medtronic plc
    • 16.3.5. Stryker Corporation
    • 16.3.6. Coloplast A/S
    • 16.3.7. Teleflex Incorporated
    • 16.3.8. Becton, Dickinson and Company
    • 16.3.9. STERIS plc
    • 16.3.10. Baxter International Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UROLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UROLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLOGY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UROLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL UROLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UROLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS UROLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL UROLOGY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL UROLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. UROLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. UROLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UROLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UROLOGY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UROLOGY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UROLOGY MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UROLOGY MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UROLOGY MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UROLOGY MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UROLOGY MARKET SIZE, BY NEPHROSTOMY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UROLOGY MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UROLOGY MARKET SIZE, BY REUSABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UROLOGY MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UROLOGY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UROLOGY MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UROLOGY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UROLOGY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UROLOGY MARKET SIZE, BY CANCER DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL UROLOGY MARKET SIZE, BY STONE REMOVAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL UROLOGY MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL UROLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL UROLOGY MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL UROLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL UROLOGY MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL UROLOGY MARKET SIZE, BY HOSPITAL PURCHASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL UROLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL UROLOGY MARKET SIZE, BY CT SCAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL UROLOGY MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL UROLOGY MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL UROLOGY MARKET SIZE, BY LASER TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL UROLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL UROLOGY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS UROLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS UROLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 322. MIDDLE EAST UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 325. MIDDLE EAST UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. MIDDLE EAST UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. MIDDLE EAST UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. MIDDLE EAST UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. MIDDLE EAST UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. MIDDLE EAST UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. MIDDLE EAST UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 332. MIDDLE EAST UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 333. MIDDLE EAST UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 334. MIDDLE EAST UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 335. AFRICA UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 336. AFRICA UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 337. AFRICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. AFRICA UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. AFRICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 340. AFRICA UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 341. AFRICA UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 342. AFRICA UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 343. AFRICA UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 344. AFRICA UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 345. AFRICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 346. AFRICA UROLOGY MARKET SIZE, BY REUSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 347. AFRICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 348. AFRICA UROLOGY MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 349. AFRICA UROLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 350. AFRICA UROLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 351. AFRICA UROLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 352. AFRICA UROLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 353. AFRICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 354. AFRICA UROLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 355. AFRICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 356. AFRICA UROLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 357. AFRICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 358. AFRICA UROLOGY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 359. ASIA-PACIFIC UROLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 360. ASIA-PACIFIC UROLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 361. ASIA-PACIFIC UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 362. ASIA-PACIFIC UROLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 363. ASIA-PACIFIC UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 364. ASIA-PACIFIC UROLOGY MARKET SIZE, BY DISPOSABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 365. ASIA-PACIFIC UROLOGY MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 366. ASIA-PACIFIC UROLOGY MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 367. ASIA-PACIFIC UROLOGY MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 368. ASIA-PACIFIC UROLOGY MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 369. ASIA-PACIFIC UROLOGY MARKET S